SOHM Inc SHMN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SHMN is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $2.61 Mil
- Volume/Avg
- 2.3 Mil / 1.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
SOHM Inc is a pharmaceutical manufacturer that produces and markets generic drugs for all treatment categories. Its services include OTC – Page Under Construction, RX: Generic CDMO Services, and ABBIE Systems. The organization markets and sells its generic drugs globally but focuses on emerging markets in Africa, Latin America, Southeast Asia, and the European Union. It recognizes revenue upon the accrual of interest earned on the tax lien certificates owned, as well as liquidating revenue from properties sold that the Company received through the settlement of unredeemed tax lien certificates.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.sohm.com
Valuation
|
Metric
|
SHMN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
SHMN
|
|---|---|
Quick Ratio | — |
Current Ratio | — |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
SHMN
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Tsxgdzfw | Rknd | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Mhwcmhfyz | Cfyjzl | $68.1 Bil | |
HLN
| Haleon PLC ADR | Pmjtnvv | Scn | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Gmxsyqx | Hsg | $14.3 Bil | |
VTRS
| Viatris Inc | Fbkfwqfpb | Krpmp | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Jmldprh | Cjjyf | $11.9 Bil | |
CTLT
| Catalent Inc | Klbzsjvx | Lgtns | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Mnsrpllgl | Ytxl | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Wlbvljfjt | Dztc | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Gfjxkncj | Vczwdj | $3.4 Bil |